Acesso livre
Acesso livre

Infectologia Pediátrica

Estudo mostrou baixas taxas de COVID-19 grave em crianças internadas com infecção por SARS-CoV-2 confirmada.

18 Abr, 2022 | 15:29h

Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England – Journal of Infection

Comentário: Severe COVID-19 extremely rare among children – News Medical

Conteúdos relacionados:

[Preprint] Risk of Hospitalization, severe disease, and mortality due to COVID-19 in children with SARS-CoV-2 infection in Germany – “overall hospitalization rate associated with SARS-CoV-2 infection was 35.9 per 10,000 children, ICU admission rate was 1.7 per 10,000 and case fatality was 0.09 per 10,000”.

Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year – “In total, 99.995% of children and young people with a positive SARS-CoV-2 test survived”.

Editorial: COVID-19 vaccines for children – “Although it is true that most children experience asymptomatic or mild disease, some will get quite sick, and a small number will die. It’s why children are vaccinated against influenza, meningitis, chickenpox, and hepatitis”.

COVID-19 disease severity in children infected with the Omicron variant.

Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.

Study identifies risk factors for severe CoviD-19 in children.

A nationwide cohort study in Denmark showed Long Covid in children is rare and mainly of short duration.

International study identifies predictors of severe outcomes in children with COVID-19.

Estudo randomizado | Eficácia, segurança e imunogenicidade de uma vacina de enterovírus 71 inativado em bebês e crianças.

18 Abr, 2022 | 15:26h

Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)

M-A | Desfechos perinatais adversos associados com terapia antirretroviral baseada em inibidor de protease em gestantes vivendo com HIV.

14 Abr, 2022 | 17:32h

Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis – EClinicalMedicine

Comunicado de imprensa: Protease inhibitors safer than thought for pregnant women with HIV – University of Oxford

Estudo randomizado | Vacinação em dose única contra o HPV se mostrou efetiva entre mulheres jovens na África.

14 Abr, 2022 | 17:07h

Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women – NEJM Evidence

Comunicado de imprensa:

Study boosts support for single-dose HPV vaccine regimen – University of Washington

One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer – World Health Organization

Conteúdo relacionado: Three-year follow-up of 2-dose versus 3-dose HPV vaccine

 

Comentário no Twitter (fio – clique para saber mais)

 

Estudo de coorte | Risco de eventos adversos após Covid-19 em crianças e adolescentes dinamarqueses e efetividade da vacina da Pfizer em adolescentes.

14 Abr, 2022 | 17:04h

Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study – The BMJ

Diretriz científica AHA | Infecção por SARS-CoV-2 e manifestações cardiovasculares associadas em crianças e jovens adultos.

14 Abr, 2022 | 16:59h

SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association – Circulation

Comunicado de imprensa: Heart issues after COVID-19 uncommon in children and young adults, more research needed – American Heart Association

Comentário: COVID-19 CV Complications in Children Are Rare, Treatable: AHA Statement – TCTMD

Estudo de coorte | Preditores de doença grave em crianças com síndrome inflamatória multissistêmica após infecção pelo SARS-CoV-2.

14 Abr, 2022 | 16:58h

Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study – Canadian Medical Association Journal

Comunicado de imprensa: Children older than 5 at higher risk of COVID-19-related multisystem inflammatory syndrome – Canadian Medical Association Journal

Comentário: Older Kids More Vulnerable to MIS-C: Study – HealthDay

Gravidade da COVID-19 em crianças infectadas pela variante Ômicron.

14 Abr, 2022 | 16:49h

COVID-19 Disease Severity in Children Infected with the Omicron Variant – Clinical Infectious Diseases

Conteúdo relacionado: Cohort Study: Incidence rates and clinical outcomes of SARS-CoV-2 infection with the Omicron and Delta variants in children younger than 5 years in the US.

 

Comentário no Twitter

 

Consenso: COVID longa em crianças.

11 Abr, 2022 | 12:57h

Long COVID (post-COVID-19 condition) in children: a modified Delphi process – Archives of Disease in Childhood

Conteúdos relacionados:

First research definition for ‘Long COVID’ in kids and young people formally agreed.

Cohort Study: Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England.

A nationwide cohort study in Denmark showed Long Covid in children is rare and mainly of short duration.

Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.

M-A: Persistent symptoms following SARS-CoV-2 infection among children and young people – “Higher study quality was associated with lower prevalence of all symptoms, except loss of smell and cognitive symptoms”.

Review: Long COVID symptoms in children rarely persist beyond three months.

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Estudo de coorte | Taxas de incidência e desfechos clínicos da infecção por SARS-CoV-2 com as variantes Ômicron e Delta em crianças menores de 5 anos nos EUA.

8 Abr, 2022 | 17:27h

Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US – JAMA Pediatrics

Comentário: Omicron ‘less severe’ than Delta for children ages 4 and younger, study suggests – Case Western Reserve University

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.